Toxic peripheral neuropathies
Mar. 08, 2023
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
2-Hydroxyglutarate (2-HG) derives from the promiscuity of lactate dehydrogenase A (LDHA), malate dehydrogenase 1 (MDH1), and PHGDH in the cytoplasm and malate dehydrogenase 2 (MDH2) in the mitochondria. Mutations of IDH1 and IDH2 endow them with neomorphic enzyme activity to convert alpha-KG to D-2HG (Dang et al 2009; Ward et al 2010; Showalter et al 2017; Du and Hu 2021). L-2HG and D-2HG are removed from the mitochondria by L2HGDH and D2HGDH, respectively. Abbreviations: D-2HG, D-2-hydroxyglutarate; D2HGDH, D-2-hydroxyglutarate dehydrogenase; FAD/FADH2, flavin adenine dinucleotide; 2-HG, 2-hydroxyglutarate; IDH, isocitrate dehydrogenase; L-2HG, L-2-hydroxyglutarate; L2HGDH, L-2-hydroxyglutarate dehydrogenase; LDHA, lactate dehydrogenase A; MDH, malate dehydrogenase; NAD+/NADH, nicotinamide adenine dinucleotide ; NADP+/NADPH, nicotinamide adenine dinucleotide phosphate; PHGDH, phosphoglycerate dehydrogenase.
Dang L, White DW, Gross S, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009;462(7274):739-44.
Du X, Hu H. The roles of 2-hydroxyglutarate. Front Cell Dev Biol 2021;9:651317.
Showalter MR, Hatakeyama J, Cajka T, et al. Replication study: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Elife 2017;6:e26030.
Ward PS, Patel J, Wise DR, et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 2010;17(3):225-34.
(Source: Du X, Hu H. The roles of 2-hydroxyglutarate. Front Cell Dev Biol 2021;9:651317. Creative Commons Attribution License [CC BY].)